公开(公告)号：US07504389B2

公开(公告)日：2009-03-17

申请号：US11280724

申请日：2005-11-15

Applicant: Mark Arnold Thomas Blaskovich ,  Ted Baughman ,  Thomas Little ,  William Patt ,  Maher Qabar ,  Lauri Mario Schultz ,  Gangadhar Nagula ,  Jennifer Lynn Gage ,  James Jeffry Howbert

Inventor： Mark Arnold Thomas Blaskovich ,  Ted Baughman ,  Thomas Little ,  William Patt ,  Maher Qabar ,  Lauri Mario Schultz ,  Gangadhar Nagula ,  Jennifer Lynn Gage ,  James Jeffry Howbert

IPC: A61K31/66 ,  C07F9/02

CPC classification number: C07F9/6541 ,  C07F9/3808 ,  C07F9/4006 ,  C07F9/572 ,  C07F9/5728 ,  C07F9/59 ,  C07F9/65517

Abstract: The present invention provides compounds of Formula (I) and Formula (II) that are useful for modulating the biological activity of the protein tyrosine phosphatase-1b (PTP1B) enzyme. Compounds of this invention can be used to treat diseases and/or conditions in which the PTP1B enzyme is a factor. Such diseases and/or conditions include, but are not limited to, Type 1 diabetes, Type 2 diabetes, inadequate glucose tolerance, insulin resistance, obesity, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, low HDL levels, atherosclerosis, vascular restenosis, inflammatory bowel disease, pancreatitis, adipose cell tumors, adipose cell carcinoma, liposarcoma, dyslipidemia, cancer, and neurodegenerative diseases.

Abstract translation: 本发明提供了可用于调节蛋白酪氨酸磷酸酶-1b（PTP1B）酶的生物学活性的式（I）和式（II）的化合物。 本发明的化合物可用于治疗其中PTP1B酶是因子的疾病和/或病症。 这些疾病和/或病症包括但不限于1型糖尿病，2型糖尿病，葡萄糖耐量不足，胰岛素抵抗，肥胖症，高脂血症，高甘油三酯血症，高胆固醇血症，低HDL水平，动脉粥样硬化，血管再狭窄，炎性肠病， 胰腺炎，脂肪细胞瘤，脂肪细胞癌，脂肪肉瘤，血脂异常，癌症和神经变性疾病。

公开(公告)号：US06255494B1

公开(公告)日：2001-07-03

申请号：US08775538

申请日：1997-01-09

Applicant: Thomas Charles Britton ,  Robert Frederick Bruns, Jr. ,  Buddy Eugene Cantrell ,  Philip Arthur Hipskind ,  Karen Lynn Lobb ,  James Arthur Nixon ,  Paul Leslie Ornstein ,  Edward C. R. Smith ,  Hamideh Zarrinmayeh ,  Dennis Michael Zimmerman ,  Anne Marie Nunes ,  James Jeffry Howbert

Inventor： Thomas Charles Britton ,  Robert Frederick Bruns, Jr. ,  Buddy Eugene Cantrell ,  Philip Arthur Hipskind ,  Karen Lynn Lobb ,  James Arthur Nixon ,  Paul Leslie Ornstein ,  Edward C. R. Smith ,  Hamideh Zarrinmayeh ,  Dennis Michael Zimmerman ,  Anne Marie Nunes ,  James Jeffry Howbert

IPC: C07D23512

CPC classification number: A61K31/454 ,  C07D235/12 ,  C07D401/06 ,  C07D401/12 ,  C07D401/14 ,  C07D403/12 ,  C07D417/14

Abstract: This invention provides a series of substituted benzimidazoles which are useful in treating or preventing a condition associated with an excess of neuropeptide Y. This invention also provides methods employing these substituted benzimidazoles as well as pharmaceutical formulations with comprise as an active ingredient one or more of these compounds.

Abstract translation: 本发明提供了一系列取代的苯并咪唑，其可用于治疗或预防与过量神经肽Y相关的病症。本发明还提供了使用这些取代的苯并咪唑的方法以及包含作为活性成分的一种或多种这些 化合物。